Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death

Blood Cells, Molecules, and Diseases

Volumn 47, Issue 3, 2011, Pages 182-197

  Migliaccio, Giovanni ^a   Masiello, Francesca ^a   Tirelli, Valentina ^a   Sanchez, Massimo ^a   Varricchio, Lilian ^b   Whitsett, Carolyn ^b   Migliaccio, Anna Rita ^a,b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Erythropoiesis; Ex vivo expansion; Glucocorticoids; Self renewal

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL COUNT; CELL DIVISION; CELL EXPANSION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL SELECTION; COLONY FORMING CELL; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROCYTE TRANSFUSION; ERYTHROID PRECURSOR CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANEMIA; APOPTOSIS; AUTOPHAGY; BLOOD TRANSFUSION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; ERYTHROBLASTS; ERYTHROCYTES; ERYTHROPOIESIS; GLUCOCORTICOIDS; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING;

EID: 80053384270     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2011.06.001     Document Type: Article

References (65)

1. Cushing M.M., Ness P.M. Principles of red blood cell transfusion. Hematology: Basic Principles and Practise 2009, 2209-2218. Churchill Livingstone, New York. ed. 5. R. Hoffman, E.J. Benz, S. Shattil (Eds.).
2. Papayannopoulou T., Abkowitz J., D'Andrea A., Migliaccio A.R. Biology of erythtropoiesis, erythroid differentiation and maturation. Hematology: Basic Principles and Practise 2009, 276-294. Churchill Livignstone, New York. ed. 5. R. Hoffman, E.J. Benz, S. Shattil (Eds.).
3. Yee D.L., Bollard C.M., Geaghan S.M. Appendix: normal blood values: selected reference, values for neonatal, pediatric, and adult populations. Hematology: Basic Principles and Practise 2009, 2431-2442. Churchill Livingstone, New York. ed. 5. R. Hoffman, E.J. Benz, S. Shattil (Eds.).
4. Surgenor D.M. Progress toward a National Blood System. The American Blood Commission. N. Engl. J. Med. 1976, 294:1367-1371.
5. Wallace E.L. Monitoring the nation's blood supply. Transfusion 2003, 43:299-301.
6. Nightingale S., Wanamaker V., Silverman B., McCurdy P., McMurtry L., Quarles P., et al. Use of sentinel sites for daily monitoring of the US blood supply. Transfusion 2003, 43:364-372.
7. Sullivan M.T., Cotten R., Read E.J., Wallace E.L. Blood collection and transfusion in the United States in 2001. Transfusion 2007, 47:385-394.
8. Alter H.J., Stramer S.L., Dodd R.Y. Emerging infectious diseases that threaten the blood supply. Semin. Hematol. 2007, 44:32-41.
9. Ahrens N., Pruss A., Kahne A., Kiesewetter H., Salama A. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion. Transfusion 2007, 47:813-816.
10. Crawford S.O., Reich N.G., An M.W., Brookmeyer R., Louis T.A., Nelson K.E., et al. Regional and temporal variation in American Red Cross blood donations, 1995 to 2005. Transfusion 2008, 48:1576-1583.
11. Reesink H.W., Engelfriet C.P., Schennach H., Gassner C., Wendel S., Fontao-Wendel R., et al. Donors with a rare pheno (geno) type. Vox Sang. 2008, 95:236-253.
12. Mohandas N. Banking on red blood cells. Nat. Biotechnol. 2005, 23:35-36.
13. Migliaccio A.R., Whitsett C., Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr. Opin. Hematol. 2009, 16:259-268.
14. Douay L., Lapillonne H., Turhan A.G. Stem cells-a source of adult red blood cells for transfusion purposes: present and future. Crit. Care Clin. 2009, 25:383-398.
15. Hiroyama T., Miharada K., Sudo K., Danjo I., Aoki N., Nakamura Y. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One 2008, 3:e1544.
16. Migliaccio G., Di Pietro R., di Giacomo V., Di Baldassarre A., Migliaccio A.R., Maccioni L., et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol. Dis. 2002, 28:169-180.
17. Boehm D., Murphy W.G., Al-Rubeai M. The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production. J. Biotechnol. 2009, 144:127-134.
18. Neildez-Nguyen T.M., Wajcman H., Marden M.C., Bensidhoum M., Moncollin V., Giarratana M.C., et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat. Biotechnol. 2002, 20:467-472.
19. Lu S.J., Feng Q., Park J.S., Vida L., Lee B.S., Strausbauch M., Wettstein P.J., Honig G.R., Lanza R. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008, 112:4475-4484.
20. Ma F., Ebihara Y., Umeda K., Sakai H., Hanada S., Zhang H., et al. Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc. Natl Acad. Sci. U. S. A. 2008, 105:13087-13092.
21. Kaufman D.S., Hanson E.T., Lewis R.L., Auerbach R., Thomson J.A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. U. S. A. 2001, 98:10716-10721.
22. Lengerke C., Grauer M., Niebuhr N.I., Riedt T., Kanz L., Park I.H., et al. Hematopoietic development from human induced pluripotent stem cells. Ann. N. Y. Acad. Sci. 2009, 1176:219-227.
23. Choi K.D., Yu J., Smuga-Otto K., Salvagiotto G., Rehrauer W., Vodyanik M., et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009, 27:559-567.
24. Chang K.H., Huang A., Hirata R.K., Wang P.R., Russell D.W., Papayannopoulou T. Globin phenotype of erythroid cells derived from human induced pluripotent stem cells. Blood 2010, 115:2553-2554.
25. Hochedlinger K., Kathrin P. Epigenetic reprogramming and induced pluripotency. Development 2009, 136:509-523.
26. Olivier E.N., Qiu C., Velho M., Hirsch R.E., Bouhassira E.E. Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp. Hematol. 2006, 34:1635-1642.
27. Bender J.G., Unverzagt K.L., Walker D.E., Lee W., Van Epps D.E., Smith D.H., et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991, 77:2591-2596.
28. Wong A., Yuen P.M., Li K., Yu A.L., Tsoi W.C. Cord blood collection before and after placental delivery: levels of nucleated cells, haematopoietic progenitor cells, leukocyte subpopulations and macroscopic clots. Bone Marrow Transplant. 2001, 27:133-138.
29. van den Akker E., Satchwell T.J., Pellegrin S., Daniels G., Toye A.M. The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica 2010, 95:1594-1598.
30. Migliaccio A.R., Tirelli V., Masiello F., Sanchez M., Whitsett C., Migliaccio G. High levels of CD44 expression identify hematopoietic cells capable of generating great numbers of erythroid cells under HEMA conditions. Blood 2010, 116:3359a.
31. Migliaccio G., Sanchez M., Masiello F., Tirelli V., Varricchio L., Whitsett C., et al. Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant. 2010, 19:453-469.
32. De Maria R., Zeuner A., Eramo A., Domenichelli C., Bonci D., Grignani F., et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 1999, 401:489-493.
33. Zhang J., Ney P.A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009, 16:939-946.
34. Wang S.H., Shih Y.L., Ko W.C., Wei Y.H., Shih C.M. Cadmium-induced autophagy and apoptosis are mediated by a calcium signaling pathway. Cell. Mol. Life Sci. 2008, 65:3640-3652.
35. Bialik S., Zalckvar E., Ber Y., Rubinstein A.D., Kimchi A. Systems biology analysis of programmed cell death. Trends Biochem. Sci. 2010, 35:556-564.
36. Klionsky D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 2007, 8:931-937.
37. Migliaccio G., Migliaccio A.R., Druzin M.L., Giardina P.J., Zsebo K.M., Adamson J.W. Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood 1992, 79:2620-2627.
38. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
39. Mouthon M.A., Freund M., Titeux M., Katz A., Guichard J., Breton-Gorius J., et al. Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis. Blood 1994, 84:1085-1097.
40. Hawkins E.D., Hommel M., Turner M.L., Battye F.L., Markham J.F., Hodgkin P.D. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat. Protoc. 2007, 2:2057-2067.
41. Lst'ovika J., Businsky V., Spisek R., Bartunkova J. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers. Cell. Immunol. 2009, 256:79-85.
42. Majka M., Janowska-Wieczorek A., Ratajczak J., Ehrenman K., Pietrzkowski Z., Kowalska M.A., et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001, 97:3075-3085.
43. Felli N., Pedini F., Zeuner A., Petrucci E., Testa U., Conticello C., et al. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J. Immunol. 2005, 175:1464-1472.
44. Kimberley F.C., Screaton G.R. Following a TRAIL: update on a ligand and its five receptors. Cell Res. 2004, 14:359-372.
45. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., et al. The receptor for the cytotoxic ligand TRAIL. Science 1997, 276:111-113.
46. MacFarlane M., Ahmad M., Srinivasula S.M., Fernandes-Alnemri T., Cohen G.M., Alnemri E.S. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 1997, 272:25417-25420.
47. Chagraoui H., Sabri S., Capron C., Villeval J.L., Vainchenker W., Wendling F. Expression of osteoprotegerin mRNA and protein in murine megakaryocytes. Exp. Hematol. 2003, 31:1081-1088.
48. Schmidt U., van den Akker E., Parren-van Amelsvoort M., Litos G., de Bruijn M., Gutierrez L., et al. Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors. J. Exp. Med. 2004, 199:785-795.
49. Secchiero P., Melloni E., Heikinheimo M., Mannisto S., Di Pietro R., Iacone A., et al. TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 2004, 103:517-522.
50. Bauer A., Tronche F., Wessely O., Kellendonk C., Reichardt H.M., Steinlein P., et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 1999, 13:2996-3002.
51. Yousefi S., Simon H.U. Autophagy in cells of the blood. Biochim. Biophys. Acta 2009, 1793:1461-1464.
52. McGrath K.E., Kingsley P.D., Koniski A.D., Porter R.L., Bushnell T.P., Palis J. Enucleation of primitive erythroid cells generates a transient population of "pyrenocytes" in the mammalian fetus. Blood 2008, 111:2409-2417.
53. Stellacci E., Di Noia A., Di Baldassarre A., Migliaccio G., Battistini A., Migliaccio A.R. Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells. Exp. Hematol. 2009, 37:559-572.
54. Dolznig H., Grebien F., Deiner E.M., Stangl K., Kolbus A., Habermann B., et al. Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR. Oncogene 2006, 25:2890-2900.
55. von Lindern M., Zauner W., Mellitzer G., Steinlein P., Fritsch G., Huber K., et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 1999, 94:550-559.
56. Leberbauer C., Boulmé F., Unfried G., Huber J., Beug H., Müllner E.W. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 2005, 105:85-94.
57. Blobel G.A., Orkin S.H. Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol. Cell. Biol. 1996, 16:1687-1694.
58. Calado R.T., Yewdell W.T., Wilkerson K.L., Regal J.A., Kajigaya S., Stratakis C.A., et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009, 114:2236-2243.
59. England S.J., McGrath K.E., Frame J.M., Palis J. Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 2011, 117:2708-2717.
60. Ziegler B.L., Muller R., Valtieri M., Lamping C.P., Thomas C.A., Gabbianelli M., et al. Unicellular-unilineage erythropoietic cultures: molecular analysis of regulatory gene expression at sibling cell level. Blood 1999, 93:3355-3368.
61. Testa U. Apoptotic mechanisms in the control of erythropoiesis. Leukemia 2004, 18:1176-1199.
62. Laane E., Tamm K.P., Buentke E., Ito K., Kharaziha P., Oscarsson J., et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ. 2009, 16:1018-1029.
63. Dainiak N., Warren G., Sutter D., Kreczko S., Howard D. A monoclonal antibody to exfoliated surface vesicles that recognizes a membrane-associated erythroid burst-promoting activity. Blood 1988, 72:989-994.
64. Keerthivasan G., Small S., Liu H., Wickrema A., Crispino J.D. Vesicle trafficking plays a novel role in erythroblast enucleation. Blood 2010, 116:3331-3340.
65. Sprick M.R., Weigand M.A., Rieser E., Rauch C.T., Juo P., Blenis J., et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000, 12:599-609.